The influence of zoledronic acid on the treatment of endocrine-responsive early breast cancer

Frontline treatments for lymphomas

EHA 2010: Experts discuss treatment of elderly cancer patients

A new centre of excellence for lung cancer treatment

Clinical trial Design: Comparator arms

Primary end points of clinical trials - overall survival versus progression free survival.

New agent eribulin prolongs survival in metastatic breast cancer

Current techniques in the treatment of lung cancer

Results of the multiple myeloma study comparing zoledronic acid to clodronate

Using oncopolicy to tackle issue of ageism in cancer treatment

Tackling ageism in cancer treatment

The role of patient advocacy groups and the efforts being made to help improve the spread and accessibility of information for patients